A GI Doc's Take on the 2021 UGIB Guidelines

Upper GI bleeding management has shifted toward tighter risk stratification, more selective transfusion, and less reflexive overnight endoscopy. A Glasgow Blatchford Score of 0-1 identifies very-low-risk patients for discharge, while unstable hemorrhage, suspected varices, and anticoagulation reversal still demand a more nuanced bedside approach.

UGIB Risk Stratification and Disposition

• Glasgow Blatchford low risk: A Glasgow Blatchford Score of 0-1 is the key discharge cutoff in the 2021 ACG guidance, identifying very-low-risk UGIB patients who can usually avoid admission with prompt GI follow-up.
• Clinical override for liver disease: A reassuring score should not overrule bedside concern for occult cirrhosis or varices; a history of alcohol use, stigmata of liver disease, or exam findings may justify a more conservative plan.
• Restrictive transfusion threshold: For most UGIB patients, transfusion starts at hemoglobin 7 g/dL, with 8 g/dL favored in cardiovascular disease; exsanguinating or hypotensive patients are the important exception.
• Early instability exception: The guideline’s low-risk and restrictive-transfusion recommendations do not apply cleanly to shock physiology, where hemodynamics matter more than the first lab value. We get into those bedside exceptions in the episode.

Pre-Endoscopy Medical Therapy

• Proton pump inhibitor upfront: Pre-endoscopic PPI therapy is reasonable despite guideline uncertainty, because it appears to reduce high-risk stigmata and the need for endoscopic hemostatic therapy at index scope.
• Erythromycin before scope: Erythromycin 250 mg IV given 20-90 minutes before endoscopy improves gastric visualization by clearing clot burden and is associated with fewer repeat procedures and shorter stays.
• Octreotide for variceal concern: Octreotide is not broadly endorsed for all-comer UGIB in this guideline, but suspected variceal bleeding remains the classic indication because it lowers splanchnic blood flow.
• Antibiotics in cirrhosis: Any UGIB patient with suspected varices or underlying liver disease should get antibiotics, with ceftriaxone the usual first choice because it lowers mortality, infections, and likely rebleeding.

Endoscopy Timing and Escalation

• Twenty-four hour endoscopy window: For stable admitted patients, endoscopy within 24 hours is now the headline target; the older push for under-12-hour scoping did not improve mortality or rebleeding in trials.
• Resuscitation before urgent scope: The reason timing relaxed is practical physiology: under-resuscitated patients do worse, and a daytime endoscopy unit often offers safer resources than a rushed overnight procedure.
• Shock changes the timeline: Persistent hypotensive shock is the major exception to the 24-hour window and should trigger emergent GI involvement rather than passive adherence to the routine clock.
• Embolization after failed hemostasis: Transcatheter arterial embolization is the next-line move for bleeding ulcers after failed endoscopic therapy, and it can enter earlier when endoscopy is not feasible. We walk through that escalation point in the chapter.

References:

1. Laine L, et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding [published correction appears in Am J Gastroenterol. 2021 Nov 1;116(11):2309]. Am J Gastroenterol. 2021;116(5):899-917. PMID: 33929377.
2. Stanley AJ, Laine L, Dalton HR, et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017;356:i6432. Published 2017 Jan 4. PMID: 28053181
3. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding [published correction appears in N Engl J Med. 2013 Jun 13;368(24):2341]. N Engl J Med. 2013;368(1):11-21. PMID: 23281973
4. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 2007;356(16):1631-1640. PMID: 17442905